Life science and technology firm Sigma-Aldrich has entered into an exclusive global distribution agreement with Switzerland-based Roche for biochemical reagents product portfolio.
Sigma-Aldrich research president and executive vice-president Eric Green said: "Sigma-Aldrich is excited to offer the global scientific community access to Roche’s leading portfolio of scientific tools and reagents.
"The addition of these life science tools supports our strategy to augment our portfolio with products that accelerate customer scientific research programs."
As part of the deal, Sigma-Aldrich will distribute Roche biochemical reagents product portfolio, including kits and enzymes for cellular analysis, proteomics and conventional PCR applications.
The products, which are currently available through existing Roche channels, will be shifted to Sigma-Aldrich in this year.
Roche molecular diagnostics head Paul Brown said: "This agreement allows us to provide more customers with access to high-quality Roche Biochemical Reagent products through Sigma-Aldrich’s expanded eCommerce and distribution networks."
Based in Basel, Roche carries out research in pharmaceutical and diagnostic fields, including applications in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
Image: The administration and R&D buildings, Roche Diagnostics Ltd, Rotkreuz. Photo: courtesy of F. Hoffmann-La Roche Ltd.